South Bangalore Facility 2, India
South Bangalore Facility 1, India
North Bangalore Facility, India
/*! elementor - v3.6.6 - 08-06-2022 */ .elementor-widget-text-editor.elementor-drop-...
Outsourcing Formulation Development & Manufacturing: Meeting Demand for Biologics & Specialty Drugs
Stelis Concludes US$ 195M Series B and Series C Fund Raise
Overcoming Biologic Drug Formulation Hurdles
